China is rapidly emerging as a pivotal force in the Asia-Pacific women’s digital health market. With significant investments in technology, a burgeoning health-tech startup ecosystem, and proactive government support, the nation is reshaping the landscape of women’s healthcare across the region.
The women’s digital health market in China is experiencing robust growth. In 2023, the market was valued at approximately USD 131.1 million and is projected to reach USD 564.5 million by 2030, registering a compound annual growth rate (CAGR) of 23.2% from 2024 to 2030.
This growth is fueled by increasing awareness of women’s health issues, the proliferation of digital health solutions, and a supportive regulatory environment.
Mobile health applications dominate China’s women’s digital health market, accounting for 65.75% of the revenue share in 2023. These apps offer services ranging from menstrual tracking to fertility monitoring, catering to the evolving needs of women.
Wearable health devices are the fastest-growing segment, anticipated to witness significant adoption due to their ability to provide real-time health monitoring and personalized insights.
Diagnostic tools are projected to reach USD 240.5 million by 2032, growing at a CAGR of 27.40% from 2023 to 2032. These tools enhance early detection and management of women’s health conditions.
In the broader Asia-Pacific context, the women’s digital health market is projected to grow from USD 724.17 million in 2024 to USD 5,691.42 million by 2034, at a CAGR of 22.74%. China’s significant investments and advancements position it as a key contributor to this regional growth.
The Chinese government has implemented several initiatives to promote digital health, including:
“Healthy China 2030” Plan: Aims to improve healthcare services and promote health education.
Telemedicine Expansion: Policies encouraging the development and adoption of telehealth services, especially in rural areas.
These initiatives create a conducive environment for the growth of women’s digital health solutions.
China’s focus on integrating artificial intelligence (AI) and big data analytics into healthcare is set to revolutionize women’s health services. Innovations in personalized medicine, predictive analytics, and remote monitoring are expected to enhance the quality and accessibility of care.
Source :
Towards Healthcare. “Asia-Pacific Women’s Digital Health Market Sizing.” Linktowardshealthcare.com
The United States gene therapy market is experiencing significant growth, driven by advancements in genetic research, increased investment, and a… Read More
Germany is emerging as a leader in Europe’s women’s digital health market, propelled by a robust healthcare infrastructure, progressive digital… Read More
The United States continues to dominate the global protein expression technology market, driven by robust research infrastructure, significant investments in… Read More
The United States continues to lead the global genomics life science analytics market, driven by technological advancements, increasing demand for… Read More
The United Kingdom is rapidly emerging as a global leader in artificial intelligence (AI) and machine learning (ML) applications within… Read More
Germany stands at the forefront of Adeno-Associated Virus (AAV) gene therapy in Europe, driven by a robust biotech ecosystem, significant… Read More